64. Jahrestagung der Deutschen Gesellschaft für Phlebologie

CHOOSING WISELY

GEMEINSAM KLUG ENTSCHEIDEN

IN DER PHLEBOLOGIE

29.9.2022 – 1.10.2022

HCC Hannover Congress Centrum
Theodor-Heuss-Platz 1-3
30175 Hannover

Hannover Neues Rathaus

Partner

We thank the following partners for their support of the 64th Annual Meeting of the German Society for Phlebology

Bauerfeind
Juzo
medi
SIGVARIS Group
medtronic
medtronic
medtronic
Walk Vascular
biolitec
Walk Vascular
Siemens
kreussler Pharma

Exhibitors

Alchimedus Management GmbH

Alpinion Medical Deutschland GmbH

Apotheken- und Ärzte-Abrechnungszentrum Dr. Güldener GmbH

Bauerfeind AG

biolitec biomedical technology GmbH

BÖSL Medizintechnik GmbH

Boston Scientific Medizintechnik GmbH

Bristol-Myers-Squibb GmbH & Co. KGaA – Pfizer

BSN-JOBST GmbH

Chemische Fabrik Kreussler & Co. GmbH

C. R. Bard GmbH

Coloplast GmbH

ConvaTec Germany GmbH

Eleanus Medical AG

ELCAT medical systems GmbH

Esaote Biomedica Deutschland GmbH

Human Med GmbH

iMS Medical

intros Medical Laser GmbH

IVM plus GmbH

Julius Zorn GmbH

KaMedi GmbH

Kosmetik vom Wasserfall GmbH

Kröner Medizintechnik GmbH

LEO Pharma GmbH

Ligamed medical Produkte GmbH

Lohmann & Rauscher GmbH & Co. KG

MEDI GmbH & Co. KG

Medizintechnik Rostock GmbH

Medtronic GmbH

Möller Medical GmbH

Mölnlycke Health Care GmbH

Mylan Germany GmbH a Viatris Company

neoplas med GmbH

Optimed Medizinische Instrumente GmbH

Paul Hartmann AG

Pharmore GmbH

PraxiMed Vertriebs GmbH

PVS HAG GmbH

sanaFactur GmbbH

Sigvaris GmbH

Smith & Nephew GmbH

Solidea Deutschland

SOT Medical Systems

Spead Doppler-Systeme Vertriebs GmbH

Thuasne Deutschland GmbH

URGO GmbH

Villa Sana GmbH & Co. medizinische Produkte KG

WPV Wirtschafts- und Praxisverlag GmbH

Transparency

The member companies of the “Freiwilligen Selbstkontrolle für die Arzneimittelindustrie e.V.” (FSA) have tightened the FSA Code to create more transparency. In future, congress organizers will be obliged to inform potential congress participants in advance of the event about the scope and conditions of support for the pharmaceutical industry.
We meet this obligation and inform you about the amount of sponsorship of the companies involved:
Bauerfeind AG 41.950,-€; Bayer Vital GmbH 1.000,-€; biolitec biomedical technology GmbH 6.400,-€; Bristol-Myers-Squibb GmbH & Co. KGaA – Pfizer 14.000,-€; Chem. Fabrik Kreussler & Co. GmbH 6.000,- €; Coloplast GmbH 500,- €; LEO Pharma GmbH 17.650,-€; Medtronic GmbH 26.100,-€; Mylan Germany GmbH a Viatris Company 11.400,-€; Pharmore GmbH 2.520,-€;  Villa Sana GmbH & Co. Medizinische Produkte KG 2.400,-€. (Stand August 2022)

The total amount of expenses is: 420.000,- €.

Sponsorship & neutrality
The contents of the congress are product and service neutral. There are no conflicts of interest on the part of the organizer. There are conflicts of interest on the part of the scientific management and the speakers, these are disclosed.

Media Partner

Gefäßchirurgie
Springer Medizin
Thieme Verlag
WPV

If you are also interested as a partner/exhibitor in the 64th Annual Meeting of the German Society for Phlebology,
please contact:
Heidrun Daldrup
Sponsoring & Exhibition
Tel.: +49 611 204809-287
Fax: +49 611 204809-10
heidrun.daldrup@wikonect.de